Issue 44, 2022, Issue in Progress

Bioorthogonal site-selective conjugation of fluorescent dyes to antibodies: method and potential applications

Abstract

Antibodies are immensely useful tools for biochemical research and have found application in numerous protein detection and purification methods. Moreover, monoclonal antibodies are increasingly utilised as therapeutics or, conjugated to active pharmaceutical ingredients, in targeted chemotherapy. Several reagents and protocols are reported to synthesise fluorescent antibodies for protein target detection and immunofluorescence applications. However, most of these protocols lead to non-selective conjugation, over-labelling or in the worst case antigen binding site modification. Here, we have used the antibody disulphide cleavage and re-bridging strategy to introduce bright fluorescent dyes without loss of the antibody function. The resulting fluorescent IgG1 type antibodies were shown to be effective imaging tools in western blot and direct immunofluorescence experiments.

Graphical abstract: Bioorthogonal site-selective conjugation of fluorescent dyes to antibodies: method and potential applications

Supplementary files

Article information

Article type
Paper
Submitted
05 Sep 2022
Accepted
27 Sep 2022
First published
05 Oct 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 28306-28317

Bioorthogonal site-selective conjugation of fluorescent dyes to antibodies: method and potential applications

P. Grossenbacher, M. C. Essers, J. Moser, S. A. Singer, S. Häusler, B. Stieger, J. Rougier and M. Lochner, RSC Adv., 2022, 12, 28306 DOI: 10.1039/D2RA05580E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements